Thomas A - Search Results

1

First use of the anti-VWF nanobody caplacizumab to treat iTTP in pregnancy.

Kühne L, Völker LA, Hagmann H, Hägele H, Osterholt T, Eichenauer DA, Thomas A, Breuer J, Grüttner B, Gottschalk I, Kann M, Benzing T, Thevis M, Müller AM, Brinkkoetter PT. Kühne L, et al. Among authors: thomas a. Br J Haematol. 2022 Feb;196(3):e30-e33. doi: 10.1111/bjh.17833. Epub 2021 Sep 29. Br J Haematol. 2022. PMID: 34585743 No abstract available.

2

Qualitative determination of synthetic analogues of insulin in human plasma by immunoaffinity purification and liquid chromatography-tandem mass spectrometry for doping control purposes.

Thevis M, Thomas A, Delahaut P, Bosseloir A, Schänzer W. Thevis M, et al. Among authors: thomas a. Anal Chem. 2005 Jun 1;77(11):3579-85. doi: 10.1021/ac050066i. Anal Chem. 2005. PMID: 15924392

3

Doping control analysis of intact rapid-acting insulin analogues in human urine by liquid chromatography-tandem mass spectrometry.

Thevis M, Thomas A, Delahaut P, Bosseloir A, Schänzer W. Thevis M, et al. Among authors: thomas a. Anal Chem. 2006 Mar 15;78(6):1897-903. doi: 10.1021/ac052095z. Anal Chem. 2006. PMID: 16536426

4

Mass spectrometric identification and characterization of a new long-term metabolite of metandienone in human urine.

Schänzer W, Geyer H, Fusshöller G, Halatcheva N, Kohler M, Parr MK, Guddat S, Thomas A, Thevis M. Schänzer W, et al. Among authors: thomas a. Rapid Commun Mass Spectrom. 2006;20(15):2252-8. doi: 10.1002/rcm.2587. Rapid Commun Mass Spectrom. 2006. PMID: 16804957

5

Mass spectrometric identification of degradation products of insulin and its long-acting analogues in human urine for doping control purposes.

Thomas A, Thevis M, Delahaut P, Bosseloir A, Schänzer W. Thomas A, et al. Anal Chem. 2007 Mar 15;79(6):2518-24. doi: 10.1021/ac062037t. Epub 2007 Feb 15. Anal Chem. 2007. PMID: 17300174

6

Mass spectrometric determination of insulins and their degradation products in sports drug testing.

Thevis M, Thomas A, Schänzer W. Thevis M, et al. Among authors: thomas a. Mass Spectrom Rev. 2008 Jan-Feb;27(1):35-50. doi: 10.1002/mas.20154. Mass Spectrom Rev. 2008. PMID: 18000882 Review.

7

Insulins in equine urine: qualitative analysis by immunoaffinity purification and liquid chromatography/tandem mass spectrometry for doping control purposes in horse-racing.

Kuuranne T, Thomas A, Leinonen A, Delahaut P, Bosseloir A, Schänzer W, Thevis M. Kuuranne T, et al. Among authors: thomas a. Rapid Commun Mass Spectrom. 2008;22(3):355-62. doi: 10.1002/rcm.3360. Rapid Commun Mass Spectrom. 2008. PMID: 18181226

8

Determination of benzimidazole- and bicyclic hydantoin-derived selective androgen receptor antagonists and agonists in human urine using LC-MS/MS.

Thevis M, Kohler M, Thomas A, Maurer J, Schlörer N, Kamber M, Schänzer W. Thevis M, et al. Among authors: thomas a. Anal Bioanal Chem. 2008 May;391(1):251-61. doi: 10.1007/s00216-008-1882-6. Epub 2008 Feb 13. Anal Bioanal Chem. 2008. PMID: 18270691

9

Rapid screening of polysaccharide-based plasma volume expanders dextran and hydroxyethyl starch in human urine by liquid chromatography-tandem mass spectrometry.

Guddat S, Thevis M, Thomas A, Schänzer W. Guddat S, et al. Among authors: thomas a. Biomed Chromatogr. 2008 Jul;22(7):695-701. doi: 10.1002/bmc.986. Biomed Chromatogr. 2008. PMID: 18348337

10

Analysis of confiscated black market drugs using chromatographic and mass spectrometric approaches.

Thevis M, Schrader Y, Thomas A, Sigmund G, Geyer H, Schänzer W. Thevis M, et al. Among authors: thomas a. J Anal Toxicol. 2008 Apr;32(3):232-40. doi: 10.1093/jat/32.3.232. J Anal Toxicol. 2008. PMID: 18397575

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9,947 results

Search Page

Filters